Cervical Cancer
Low podoplanin expression predicts poor prognosis in advanced-stage squamous cell carcinoma
Published in Women's Health Weekly, July 6th, 2006
"Lymphatic invasion and nodal metastasis are predictors of poor outcome in cervix carcinoma. We have recently found that low podoplanin immunoreactivity in cervix carcinoma correlated with the presence of lymphatic invasion and nodal metastasis.
"In the current study, we examined whether podoplanin expression in pretreatment cervical biopsies can predict the presence lymphatic invasion, nodal metastasis, and outcome in advanced-stage tumors treated by nonsurgical means," researchers in the United States report.
"Podoplanin expression was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Arthritis
Decline in physical functioning for women in midlife may begin earlier than expected - Cardiovascular Disease
Cardiac autonomic regulation may be positively affected by raloxifene - HIV/AIDS Transmission
Single-dose nevirapine studies would enhance understanding of nevirapine-resistant HIV-1 - Uterine Cancer
Uterine serous papillary cancer may be diagnosed by elevated serum kallikrein 10 - Autoimmune Disease
Anticardiolipin detection in infants best assay to evaluate disappearance of maternal aPL - Bladder Cancer
Microscopic hematuria in women with voiding symptoms is not predictive for bladder cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
